Direct measurement of serum low-density lipoprotein cholesterol in patients with acute myocardial infarction on admission to the emergency room

American Journal of Cardiology

Volumn 77, Issue 14, 1996, Pages 1232-1234

  Van Dis, Frederic J ^a   Keilson, Leonard M ^a   Rundell, Clark A ^a   Rawstron, Ming W ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EMERGENCY WARD; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

EID: 0030011203     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00170-1     Document Type: Article

References (9)

1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972;18:449-502.
2. Wilder LB, Bachorik PS, Finney CA, Moy TF, Becker DM. The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol. Am J Med 1995; 99:374-377.
3. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol 1993;22:933-940.
4. Belcher JD, McNamara JR, Gringstead GF, Rafai N, Warnick GR, Bachorik P. Laboratory Measurement of Lipids, Lipoproteins, and Apolipoproteins. 2nd ed. In: Rafai N, Warnick GR, eds. Washington, D.C.: American Association for Clinical Chemistry Press, 1994:107-124.
5. LDL Cholesterol Procedure Manual No. 353. St. Louis, Missouri: Sigma Diagnostics: 1995.
6. Consensus panel statement: preventing heart attack and death in patients with coronary disease. Circulation 1995;92:1-4.
7. Pedersen TR, Kjekshus J, Berg K, Haghfelt T, Faergeman O, Thorgeirsson G, Pyorala K, Miettinen T, Wilhelmsen L, Olsson AG, Wedel H. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389
8. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-487.
9. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation 1994;89:1530-1538.